Healthcare provider profile · identity verified

Mark S. Rozick, M.D.

Family Practice · BELLEFONTE, PA · NPI 1003872128

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1190	302
Lisinopril	Lisinopril	552	134
Omeprazole	Omeprazole	548	150
Levothyroxine Sodium	Levothyroxine Sodium	481	118
Amlodipine Besylate	Amlodipine Besylate	415	109
Metformin Hcl Er	Metformin Hcl	343	98
Gabapentin	Gabapentin	327	82
Losartan Potassium	Losartan Potassium	326	91
Hydrochlorothiazide	Hydrochlorothiazide	302	70
Metoprolol Succinate	Metoprolol Succinate	279	78
Rosuvastatin Calcium	Rosuvastatin Calcium	261	73
Allopurinol	Allopurinol	235	50
Jardiance	Empagliflozin	231	57
Trazodone Hcl	Trazodone Hcl	219	50
Metformin Hcl	Metformin Hcl	199	51
Tramadol Hcl	Tramadol Hcl	199	38
Tamsulosin Hcl	Tamsulosin Hcl	191	60
Escitalopram Oxalate	Escitalopram Oxalate	178	46
Lorazepam	Lorazepam	162	36
Pantoprazole Sodium	Pantoprazole Sodium	162	42
Furosemide	Furosemide	157	48
Metoprolol Tartrate	Metoprolol Tartrate	154	34
Potassium Chloride	Potassium Chloride	141	40
Albuterol Sulfate Hfa	Albuterol Sulfate	133	50
Eliquis	Apixaban	123	28
Fluticasone Propionate	Fluticasone Propionate	121	56
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	33
Alendronate Sodium	Alendronate Sodium	118	29
Simvastatin	Simvastatin	118	33
Atenolol	Atenolol	112	26
Citalopram Hbr	Citalopram Hydrobromide	112	30
Ozempic	Semaglutide	108	21
Finasteride	Finasteride	105	28
Trulicity	Dulaglutide	103	22
Prednisone	Prednisone	100	57
Clopidogrel	Clopidogrel Bisulfate	99	29
Famotidine	Famotidine	94	30
Triamcinolone Acetonide	Triamcinolone Acetonide	94	47
Glipizide Er	Glipizide	91	25
Montelukast Sodium	Montelukast Sodium	91	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	26
Fluoxetine Hcl	Fluoxetine Hcl	88	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	13
Warfarin Sodium	Warfarin Sodium	78	23
Glipizide	Glipizide	76	22
Clonazepam	Clonazepam	73	14
Diclofenac Sodium	Diclofenac Sodium	72	29
Spironolactone	Spironolactone	72	21
Oxycodone Hcl	Oxycodone Hcl	69	suppressed
Duloxetine Hcl	Duloxetine Hcl	67	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	21
Carvedilol	Carvedilol	62	14
Sertraline Hcl	Sertraline Hcl	59	15
Hydroxyzine Hcl	Hydroxyzine Hcl	55	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Venlafaxine Hcl Er	Venlafaxine Hcl	51	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	12
Pregabalin	Pregabalin	47	suppressed
Baclofen	Baclofen	46	suppressed
Cephalexin	Cephalexin	44	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	11
Meloxicam	Meloxicam	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Buspirone Hcl	Buspirone Hcl	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Synthroid	Levothyroxine Sodium	36	suppressed
Ezetimibe	Ezetimibe	35	11
Alprazolam	Alprazolam	32	suppressed
Azithromycin	Azithromycin	32	26
Ketoconazole	Ketoconazole	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Nitroglycerin	Nitroglycerin	28	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	22
Methylphenidate Hcl	Methylphenidate Hcl	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Fentanyl	Fentanyl	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	16
Nystatin	Nystatin	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Klor-Con M10	Potassium Chloride	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Cimetidine	Cimetidine	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Clotrimazole	Clotrimazole	18	11
Jantoven	Warfarin Sodium	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Fluconazole	Fluconazole	17	13
Mirtazapine	Mirtazapine	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Valsartan	Valsartan	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Clonidine	Clonidine	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Mupirocin	Mupirocin	16	12
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Azelastine Hcl	Azelastine Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Zonisamide	Zonisamide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Primidone	Primidone	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nyamyc	Nystatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error